LAZARD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.99 USD | +0.26% |
|
+2.85% | +12.04% |
| 04-25 | The specter of stagflation rears its ugly head again |  |
| 04-25 | Transcript : Lazard, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
Strengths
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Investment Management & Fund Operators
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +12.04% | 3.41B | B+ | ||
| -6.03% | 113B | A- | ||
| -3.98% | 87.91B | C+ | ||
| +20.96% | 63.76B | C | ||
| +5.29% | 61.9B | - | B+ | |
| +10.12% | 42.86B | C+ | ||
| +7.95% | 40.84B | A- | ||
| +18.92% | 34.58B | A- | ||
| +5.88% | 25.48B | B | ||
| -5.25% | 22.13B | A- |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- LAZ Stock
- LAZ Stock
- Ratings Lazard
